202 related articles for article (PubMed ID: 34078439)
21. The Prognostic Values of the Insulin-Like Growth Factor Binding Protein Family in Ovarian Cancer.
Zheng R; Chen W; Xia W; Zheng J; Zhou Q
Biomed Res Int; 2020; 2020():7658782. PubMed ID: 33282953
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Analysis of Expression and Prognostic Value of GATAs in Lung Cancer.
Gong C; Fan Y; Zhou X; Lai S; Wang L; Liu J
J Cancer; 2021; 12(13):3862-3876. PubMed ID: 34093794
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive bioinformatics analysis to identify a candidate prognostic biomarker for ovarian cancer.
Zhu H; Yue H; Xie Y; Du Q; Chen B; Zhou Y; Liu W
Transl Cancer Res; 2021 Mar; 10(3):1537-1548. PubMed ID: 35116478
[TBL] [Abstract][Full Text] [Related]
24. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
25. The potential value of microRNA-145 for predicting prognosis in patients with ovarian cancer: A protocol for systematic review and meta-analysis.
Chen Z; Xiao Z; Zeng S; Yan Z
Medicine (Baltimore); 2021 Aug; 100(32):e26922. PubMed ID: 34397934
[TBL] [Abstract][Full Text] [Related]
26. Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer.
Gong G; Lin T; Yuan Y
J Ovarian Res; 2020 Mar; 13(1):30. PubMed ID: 32192517
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive bioinformatics analysis confirms RBMS3 as the central candidate biological target for ovarian cancer.
Wang M; Fu X; Wang W; Zhang Y; Jiang Z; Gu Y; Chu M; Shao Y; Li S
Med Eng Phys; 2022 Dec; 110():103883. PubMed ID: 36075788
[TBL] [Abstract][Full Text] [Related]
28. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
[TBL] [Abstract][Full Text] [Related]
29. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
30. Inhibitor of DNA-binding family regulates the prognosis of ovarian cancer.
Zhou Q; Mei YD; Yang HJ; Tao YL
Future Oncol; 2021 May; 17(15):1889-1906. PubMed ID: 33728938
[No Abstract] [Full Text] [Related]
31. Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis.
Cao T; Pan W; Sun X; Shen H
J Ovarian Res; 2019 Oct; 12(1):101. PubMed ID: 31656201
[TBL] [Abstract][Full Text] [Related]
32. Identification of SOCS family members with prognostic values in human ovarian cancer.
Yang M; Chen H; Zhou L; Huang X; Su F; Wang P
Am J Transl Res; 2020; 12(5):1824-1838. PubMed ID: 32509179
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
Xue B; Li S; Jin X; Liu L
BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
[TBL] [Abstract][Full Text] [Related]
34. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
35. Distinct expression and prognostic value of members of the epidermal growth factor receptor family in ovarian cancer.
Zhou Q; Hou CN; Yang HJ; He Z; Zuo MZ
Cancer Manag Res; 2018; 10():6937-6948. PubMed ID: 30588099
[TBL] [Abstract][Full Text] [Related]
36. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
[TBL] [Abstract][Full Text] [Related]
37. Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer.
Zhou Q; Yang HJ; Zuo MZ; Tao YL
J Ovarian Res; 2022 Apr; 15(1):49. PubMed ID: 35488350
[TBL] [Abstract][Full Text] [Related]
38. Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes.
Chen B; Gao C; Wang H; Sun J; Han Z
Comput Math Methods Med; 2022; 2022():3268386. PubMed ID: 36213580
[TBL] [Abstract][Full Text] [Related]
39. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.
Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761
[TBL] [Abstract][Full Text] [Related]
40. SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer.
Sun T; Bi F; Liu Z; Yang Q
Aging (Albany NY); 2020 Jul; 12(13):13281-13296. PubMed ID: 32647070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
